TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced the ...
GENEVA & NOUZILLY, France--(BUSINESS WIRE)--Selexis SA and Igyxos announced today that they have entered into a service agreement to develop Igyxos’ first-in-class monoclonal antibody (mAb) drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results